Go Pro
→ Buy this stock tomorrow (From Chaikin Analytics) (Ad)tc pixel
Brian Abrahams

Brian Abrahams Analyst Performance

Analyst at Royal Bank Of Canada

Brian Abrahams is a stock analyst at Royal Bank Of Canada focused in the medical sector, covering 42 publicly traded companies. Over the past year, Brian Abrahams has issued 107 stock ratings, including buy, hold, and sell recommendations. While full access to Brian Abrahams' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Brian Abrahams' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
307 Last 11 Years
Buy Recommendations
64.38% 197 Buy Ratings
Companies Covered
42 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy64.4%197 ratings
Hold35.3%108 ratings
Sell0.3%1 ratings

Out of 306 total stock ratings issued by Brian Abrahams at Royal Bank Of Canada, the majority (64.4%) have been Buy recommendations, followed by 35.3% Hold and 0.3% Sell.

Best & Worst Calls

Exchange Coverage

ExchangePercentageCount
NASDAQ
95.2% of companies on NASDAQ
40 companies
NYSE
4.8% of companies on NYSE
2 companies

Brian Abrahams, an analyst at Royal Bank Of Canada, currently covers 42 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
41 companies		97.6%
Manufacturing
1 company		2.4%

Brian Abrahams of Royal Bank Of Canada specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
31 companies		73.8%
MED - DRUGS
5 companies		11.9%
BIOTECHNOLOGY
2 companies		4.8%
PHARMACEUTICAL PREPARATIONS
2 companies		4.8%
Miscellaneous
1 company		2.4%
MED - OUTP/HM CRE
1 company		2.4%

About Brian Abrahams

Dr. Brian Abrahams joined RBC Capital Markets in July 2017 as a senior analyst covering the biotechnology sector. He has 15 years of experience following large, mid, and small cap biotech companies, and prior to RBC spent time in biotechnology equity research at Jefferies, Wells Fargo, and CIBC World Markets / Oppenheimer & Co. He is a licensed non-practicing physician and holds a medical degree from the Albert Einstein College of Medicine. He did his undergraduate studies at Yale University, where he graduated magna cum laude with a Bachelor of Science degree in Molecular Biophysics & Biochemistry.
Follow on LinkedIn

Brian Abrahams' Ratings History at Royal Bank Of Canada

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
Export
CompanyReport DateActionReport Date Price12-Month
Price Target		Rating12-Month
Price & ROI		Details
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
7/13/2026Downgrade$119.35$115.00Sector Perform
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
7/13/2026Lower Price Target$1.62$5.00Outperform
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
7/10/2026Boost Price Target$23.97$33.00Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
7/7/2026Boost Price Target$529.59$570.00Outperform
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
7/7/2026Boost Price Target$85.44$85.00Sector Perform
Incyte Corporation stock logo
INCY
Incyte
7/7/2026Boost Price Target$115.62$99.00Sector Perform
Biogen Inc. stock logo
BIIB
Biogen
7/7/2026Boost Price Target$208.46$242.00Outperform
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
7/7/2026Boost Price Target$25.77$36.00Outperform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
7/7/2026Lower Price Target$668.88$696.00Sector Perform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
7/7/2026Boost Price Target$178.11$195.00Outperform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
7/7/2026Lower Price Target$134.71$120.00Sector Perform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
7/7/2026Boost Price Target$10.19$14.00Outperform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
6/8/2026Reiterated Rating$129.17Sector Perform
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
6/8/2026Boost Price Target$86.92$97.00Sector Perform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
6/1/2026Reiterated Rating$134.43$122.00Overweight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
6/1/2026Upgrade$131.10Moderate Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
5/29/2026Boost Price Target$157.47$183.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
5/27/2026Boost Price Target$193.08$227.00Outperform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
5/18/2026Lower Price Target$623.32$707.00Sector Perform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
5/8/2026Lower Price Target$130.55$122.00Sector Perform
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
5/8/2026Boost Price Target$79.08$82.00Sector Perform
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
5/8/2026Boost Price Target$55.89$82.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
5/6/2026Boost Price Target$144.90$180.00Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
5/5/2026Boost Price Target$429.85$543.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
4/30/2026Boost Price Target$191.32$222.00Outperform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
4/30/2026Lower Price Target$707.09$762.00Sector Perform
Biogen Inc. stock logo
BIIB
Biogen
4/29/2026Boost Price Target$191.58$222.00Outperform
Damora Therapeutics, Inc. Common Stock stock logo
DMRA
Damora Therapeutics, Inc. Common Stock
4/24/2026Initiated Coverage$25.42$40.00Outperform
Damora Therapeutics, Inc. Common Stock stock logo
DMRA
Damora Therapeutics, Inc. Common Stock
4/23/2026Upgrade$24.75Moderate Buy
Evommune, Inc. stock logo
EVMN
Evommune
4/10/2026Reiterated Rating$27.56$48.00Outperform
Pharvaris N.V. stock logo
PHVS
Pharvaris
4/6/2026Lower Price Target$28.56$51.00Outperform
Pharvaris N.V. stock logo
PHVS
Pharvaris
3/9/2026Initiated Coverage$26.63$52.00Outperform
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
3/2/2026Lower Price Target$70.92$82.00Sector Perform
Aardvark Therapeutics, Inc. stock logo
AARD
Aardvark Therapeutics
3/2/2026Downgrade$12.49$6.00Sector Perform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
3/2/2026Boost Price Target$784.09$765.00Sector Perform
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
3/2/2026Boost Price Target$17.69$13.00Sector Perform
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
2/26/2026Reiterated Rating$91.56$108.00Outperform
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
2/26/2026Lower Price Target$24.82$30.00Outperform
Lakefront Biotherapeutics American Depositary Shares stock logo
LKFT
Lakefront Biotherapeutics American Depositary Shares
2/24/2026Boost Price Target$34.36$33.00Sector Perform
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
2/20/2026Lower Price Target$69.90$82.00Sector Perform
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (Ad)

A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel

Click here to learn this company's name for free today
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
2/20/2026Boost Price Target$17.86$12.00Sector Perform
Prothena Corporation plc stock logo
PRTA
Prothena
2/20/2026Boost Price Target$8.83$12.00Sector Perform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/13/2026Lower Price Target$496.69$541.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/12/2026Lower Price Target$126.01$177.00Outperform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2/11/2026Boost Price Target$156.39$118.00Sector Perform
Incyte Corporation stock logo
INCY
Incyte
2/11/2026Lower Price Target$98.59$92.00Sector Perform
Biogen Inc. stock logo
BIIB
Biogen
2/9/2026Boost Price Target$201.18$233.00Outperform
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
2/3/2026Lower Price Target$26.13$31.00Outperform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
1/30/2026Lower Price Target$6.44$13.00Outperform
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
1/29/2026Boost Price Target$17.60$30.00Outperform
GH Research PLC stock logo
GHRS
GH Research
1/23/2026Boost Price Target$16.46$40.00Outperform
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
1/23/2026Boost Price Target$17.29$36.00Outperform
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
1/22/2026Downgrade$81.91$83.00Sector Perform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
1/22/2026Upgrade$461.14$546.00Outperform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1/20/2026Boost Price Target$124.91$103.00Sector Perform
Biogen Inc. stock logo
BIIB
Biogen
1/13/2026Reiterated Rating$178.30Outperform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1/8/2026Lower Price Target$121.35$100.00Sector Perform
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
1/8/2026Boost Price Target$21.31$18.00Sector Perform
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
1/6/2026Reiterated Rating$78.59Outperform
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
12/16/2025Boost Price Target$85.68$103.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
12/8/2025Boost Price Target$159.46$180.00Outperform
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
12/1/2025Downgrade$85.99$91.00Sector Perform
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
12/1/2025Upgrade$2.26$7.00Outperform
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
12/1/2025Reiterated Rating$43.57$24.00Underperform
Contineum Therapeutics, Inc. stock logo
CTNM
Contineum Therapeutics
11/21/2025Lower Price Target$11.08$22.00Outperform
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
11/17/2025Downgrade$217.78Sector Perform
Aardvark Therapeutics, Inc. stock logo
AARD
Aardvark Therapeutics
11/14/2025Lower Price Target$10.86$18.00Outperform
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
11/13/2025Lower Price Target$11.09$53.00Outperform
Prothena Corporation plc stock logo
PRTA
Prothena
11/7/2025Boost Price Target$10.15$11.00Sector Perform
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
11/7/2025Lower Price Target$11.26$20.00Outperform
Lakefront Biotherapeutics American Depositary Shares stock logo
LKFT
Lakefront Biotherapeutics American Depositary Shares
11/7/2025Boost Price Target$31.38$32.00Sector Perform
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
11/7/2025Boost Price Target$99.95$145.00Outperform
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
11/6/2025Lower Price Target$21.35$32.00Outperform
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
11/5/2025Boost Price Target$72.90$82.00Outperform
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
11/4/2025Boost Price Target$39.54$58.00Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
11/4/2025Lower Price Target$430.41$415.00Sector Perform
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
11/4/2025Lower Price Target$5.66$19.00Outperform
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
11/3/2025Boost Price Target$57.13$70.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
10/31/2025Lower Price Target$149.61$210.00Outperform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
10/31/2025Boost Price Target$120.73$105.00Sector Perform
Incyte Corporation stock logo
INCY
Incyte
10/29/2025Boost Price Target$89.19$84.00Sector Perform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
10/29/2025Boost Price Target$654.96$708.00Sector Perform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
10/29/2025Boost Price Target$139.82$160.00Outperform
Lakefront Biotherapeutics American Depositary Shares stock logo
LKFT
Lakefront Biotherapeutics American Depositary Shares
10/22/2025Boost Price Target$32.33$28.00Sector Perform
Biogen Inc. stock logo
BIIB
Biogen
10/8/2025Lower Price Target$152.21$217.00Outperform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
10/8/2025Boost Price Target$116.78$100.00Sector Perform
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
10/8/2025Boost Price Target$24.02$16.00Sector Perform
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
9/29/2025Reiterated Rating$6.86$10.00Sector Perform
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
9/25/2025Initiated Coverage$38.42$60.00Outperform
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
9/24/2025Set Price Target$88.16$137.00Outperform
The chipmaker 148 times smaller than NVIDIA supplying Musk (Ad)

According to Yahoo Finance, Elon Musk's latest project could 'upend another industry just as he did with cars and rockets.' Tech investor Jeff Brown - a former senior executive at Qualcomm, Juniper Networks, and NXP Semiconductors - says one tiny chipmaker, 148 times smaller than NVIDIA, is set to supply Musk with 5 billion chips over the next two years. Early investors in Tesla and SpaceX saw life-changing returns. Brown believes this overlooked chipmaker could offer a similar opportunity, with entry points currently around $50.tc pixel

Click here to see Jeff Brown's full breakdown of this chipmaker
Incyte Corporation stock logo
INCY
Incyte
9/24/2025Boost Price Target$84.54$81.00Sector Perform
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
9/16/2025Initiated Coverage$47.28$70.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
9/5/2025Boost Price Target$143.76$149.00Outperform
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
9/3/2025Initiated Coverage$25.39$22.00Sector Perform
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
9/2/2025Reiterated Rating$39.12$55.00Outperform
Aardvark Therapeutics, Inc. stock logo
AARD
Aardvark Therapeutics
8/14/2025Lower Price Target$11.44$19.00Outperform
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
8/12/2025Lower Price Target$36.96$55.00Outperform
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
8/8/2025Reiterated Rating$46.87$63.00Outperform
89BIO stock logo
ETNB
89BIO
8/8/2025Lower Price Target$8.92$11.00Sector Perform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
8/8/2025Boost Price Target$119.21$98.00Sector Perform
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
8/7/2025Boost Price Target$23.84$40.00Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
8/5/2025Lower Price Target$389.93$405.00Sector Perform
Prothena Corporation plc stock logo
PRTA
Prothena
8/5/2025Lower Price Target$7.28$10.00Sector Perform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
8/4/2025Boost Price Target$569.71$695.00Sector Perform
Biogen Inc. stock logo
BIIB
Biogen
8/1/2025Boost Price Target$126.28$219.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
7/31/2025Lower Price Target$129.41$144.00Outperform
Incyte Corporation stock logo
INCY
Incyte
7/30/2025Boost Price Target$77.88$72.00Sector Perform
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/17/2025Lower Price Target$21.46$23.00Sector Perform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
6/30/2025Reiterated Rating$9.23$13.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
6/25/2025Set Price Target$126.16$213.00Outperform
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
6/24/2025Upgrade$49.86$75.00Moderate Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
6/23/2025Boost Price Target$22.12$38.00Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
6/17/2025Set Price Target$448.47$420.00Sector Perform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
5/27/2025Reiterated Rating$599.20$662.00Sector Perform
Contineum Therapeutics, Inc. stock logo
CTNM
Contineum Therapeutics
5/15/2025Reiterated Rating$3.72$31.00Outperform
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
5/13/2025Lower Price Target$5.40$33.00Outperform
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
5/13/2025Lower Price Target$29.93$55.00Outperform
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
5/7/2025Lower Price Target$6.34$58.00Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
5/6/2025Boost Price Target$434.64$423.00Sector Perform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
5/6/2025Reiterated Rating$10.40$13.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
5/2/2025Lower Price Target$122.38$205.00Outperform
Incyte Corporation stock logo
INCY
Incyte
4/30/2025Boost Price Target$61.11$67.00Sector Perform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
4/30/2025Lower Price Target$586.51$943.00Outperform
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
4/22/2025Reiterated Rating$33.48$84.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
4/22/2025Boost Price Target$117.63$225.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
4/14/2025Upgrade$90.87$137.00Outperform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
4/11/2025Reiterated Rating$6.55$11.00Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
4/1/2025Boost Price Target$487.06$420.00Sector Perform
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
3/31/2025Downgrade$70.41$87.00Sector Perform
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
3/18/2025Initiated Coverage$38.67$67.00Outperform
Aardvark Therapeutics, Inc. stock logo
AARD
Aardvark Therapeutics
3/10/2025Initiated Coverage$10.13$21.00Outperform
GH Research PLC stock logo
GHRS
GH Research
3/7/2025Initiated Coverage$10.55$31.00Outperform
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
2/27/2025Lower Price Target$107.24$161.00Outperform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
2/25/2025Reiterated Rating$8.11$11.00Outperform
Prothena Corporation plc stock logo
PRTA
Prothena
2/21/2025Lower Price Target$15.61$20.00Sector Perform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/20/2025Boost Price Target$475.68$408.00Sector Perform
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
2/20/2025Reiterated Rating$9.41$45.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
2/13/2025Lower Price Target$135.56$225.00Outperform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2/12/2025Boost Price Target$103.52$90.00Sector Perform
Incyte Corporation stock logo
INCY
Incyte
2/11/2025Lower Price Target$68.30$68.00Sector Perform
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (Ad)

A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel

Click here to learn this company's name for free today
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/11/2025Boost Price Target$459.15$407.00Sector Perform
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
2/10/2025Downgrade$7.79$4.00Sector Perform
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
2/10/2025Reiterated Rating$9.77$45.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/7/2025Lower Price Target$122.00$148.00Sector Perform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2/3/2025Reiterated Rating$99.12$84.00Sector Perform
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
1/29/2025Reiterated Rating$104.53$139.00Outperform

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Top Stock Recommendations by Brokerage